Literature DB >> 22570484

Comparative processing and function of human and ferret cystic fibrosis transmembrane conductance regulator.

John T Fisher1, Xiaoming Liu, Ziying Yan, Meihui Luo, Yulong Zhang, Weihong Zhou, Ben J Lee, Yi Song, Chenhong Guo, Yujiong Wang, Gergely L Lukacs, John F Engelhardt.   

Abstract

The most common cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation is ΔF508, and this causes cystic fibrosis (CF). New CF models in the pig and ferret have been generated that develop lung, pancreatic, liver, and intestinal pathologies that reflect disease in CF patients. Species-specific biology in the processing of CFTR has demonstrated that pig and mouse ΔF508-CFTR proteins are more effectively processed to the apical membrane of airway epithelia than human ΔF508-CFTR. The processing behavior of ferret WT- and ΔF508-CFTR proteins remains unknown, and such information is important to predicting the utility of a ΔF508-CFTR ferret. To this end, we sought to compare processing, membrane stability, and function of human and ferret WT- and ΔF508-CFTR proteins in a heterologous expression system using HT1080, HEK293T, BHK21, and Cos7 cells as well as human and ferret CF polarized airway epithelia. Analysis of the protein processing and stability by metabolic pulse-chase and surface On-Cell Western blots revealed that WT-fCFTR half-life and membrane stability were increased relative to WT-hCFTR. Furthermore, in BHK21, Cos7, and CuFi cells, human and ferret ΔF508-CFTR processing was negligible, whereas low levels of processing of ΔF508-fCFTR could be seen in HT1080 and HEK293T cells. Only the WT-fCFTR, but not ΔF508-fCFTR, produced functional cAMP-inducible chloride currents in both CF human and ferret airway epithelia. Further elucidation of the mechanism responsible for elevated fCFTR protein stability may lead to new therapeutic approaches to augment CFTR function. These findings also suggest that generation of a ferret CFTR(ΔF508/ΔF508) animal model may be useful.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22570484      PMCID: PMC3381131          DOI: 10.1074/jbc.M111.336537

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

2.  Development of cystic fibrosis and noncystic fibrosis airway cell lines.

Authors:  Joseph Zabner; Phil Karp; Michael Seiler; Stacia L Phillips; Calista J Mitchell; Mimi Saavedra; Michael Welsh; Aloysius J Klingelhutz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-01-10       Impact factor: 5.464

3.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  Expression and characterization of the cystic fibrosis transmembrane conductance regulator.

Authors:  R J Gregory; S H Cheng; D P Rich; J Marshall; S Paul; K Hehir; L Ostedgaard; K W Klinger; M J Welsh; A E Smith
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

5.  Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer.

Authors:  M L Drumm; H A Pope; W H Cliff; J M Rommens; S A Marvin; L C Tsui; F S Collins; R A Frizzell; J M Wilson
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

Review 6.  Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator.

Authors:  W R Skach
Journal:  Kidney Int       Date:  2000-03       Impact factor: 10.612

7.  A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein.

Authors:  Carlos M Farinha; Filipa Mendes; Mónica Roxo-Rosa; Deborah Penque; Margarida D Amaral
Journal:  Mol Cell Probes       Date:  2004-08       Impact factor: 2.365

Review 8.  CFTR and chaperones: processing and degradation.

Authors:  Margarida D Amaral
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Biochemical and biophysical identification of cystic fibrosis transmembrane conductance regulator chloride channels as components of endocytic clathrin-coated vesicles.

Authors:  N A Bradbury; J A Cohn; C J Venglarik; R J Bridges
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

10.  Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes.

Authors:  Manu Sharma; Francesca Pampinella; Csilla Nemes; Mohamed Benharouga; Jeffrey So; Kai Du; Kristi G Bache; Blake Papsin; Noa Zerangue; Harald Stenmark; Gergely L Lukacs
Journal:  J Cell Biol       Date:  2004-03-08       Impact factor: 10.539

View more
  17 in total

1.  Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets.

Authors:  Xingshen Sun; Alicia K Olivier; Bo Liang; Yaling Yi; Hongshu Sui; Turan I A Evans; Yulong Zhang; Weihong Zhou; Scott R Tyler; John T Fisher; Nicholas W Keiser; Xiaoming Liu; Ziying Yan; Yi Song; J Adam Goeken; Joann M Kinyon; Danielle Fligg; Xiaoyan Wang; Weiliang Xie; Thomas J Lynch; Paul M Kaminsky; Zoe A Stewart; R Marshall Pope; Timothy Frana; David K Meyerholz; Kalpaj Parekh; John F Engelhardt
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

Review 2.  Gene delivery to the airway.

Authors:  Nicholas W Keiser; John F Engelhardt
Journal:  Curr Protoc Hum Genet       Date:  2013-07

3.  Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice.

Authors:  Mathilde Beka; Teresinha Leal
Journal:  J Vis Exp       Date:  2018-07-04       Impact factor: 1.355

4.  Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.

Authors:  Ziying Yan; Xingshen Sun; Zehua Feng; Guiying Li; John T Fisher; Zoe A Stewart; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2015-04-20       Impact factor: 5.695

Review 5.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

6.  A novel chimeric adenoassociated virus 2/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia.

Authors:  Ziying Yan; Nicholas W Keiser; Yi Song; Xuefeng Deng; Fang Cheng; Jianming Qiu; John F Engelhardt
Journal:  Mol Ther       Date:  2013-07-30       Impact factor: 11.454

7.  S-palmitoylation regulates biogenesis of core glycosylated wild-type and F508del CFTR in a post-ER compartment.

Authors:  Michelle L McClure; Hui Wen; James Fortenberry; Jeong S Hong; Eric J Sorscher
Journal:  Biochem J       Date:  2014-04-15       Impact factor: 3.857

8.  Bioelectric characterization of epithelia from neonatal CFTR knockout ferrets.

Authors:  John T Fisher; Scott R Tyler; Yulong Zhang; Ben J Lee; Xiaoming Liu; Xingshen Sun; Hongshu Sui; Bo Liang; Meihui Luo; Weiliang Xie; Yaling Yi; Weihong Zhou; Yi Song; Nicholas Keiser; Kai Wang; Hugo R de Jonge; John F Engelhardt
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

9.  Rescue of murine F508del CFTR activity in native intestine by low temperature and proteasome inhibitors.

Authors:  Martina Wilke; Alice Bot; Huub Jorna; Bob J Scholte; Hugo R de Jonge
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

10.  Nicotine Induces Progressive Properties of Lung Adenocarcinoma A549 Cells by Inhibiting Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Expression and Plasma Membrane Localization.

Authors:  Hui Li; Ningxia Ma; Jing Wang; Ying Wang; Chao Yuan; Jing Wu; Meihui Luo; Jiali Yang; Juan Chen; Juan Shi; Xiaoming Liu
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.